March 23, 2020 / 1:29 PM / 18 days ago

BRIEF-Ac Immune Receives Second Milestone And New Milestone To Increase The Potential Deal Value Of Lilly Morphomer™ Tau Partnership

March 23 (Reuters) - AC Immune SA:

* AC IMMUNE RECEIVES SECOND MILESTONE AND NEW MILESTONE TO INCREASE THE POTENTIAL DEAL VALUE OF LILLY MORPHOMER™ TAU PARTNERSHIP

* AC IMMUNE SA - WILL RECEIVE A SECOND MILESTONE PAYMENT OF CHF 10 MILLION FROM ELI LILLY

* AC IMMUNE SA - WILL NOW ALSO BE ELIGIBLE FOR A NEW CHF 60 MILLION POTENTIAL MILESTONE AFTER INITIATION OF TAU MORPHOMER PHASE 2 CLINICAL TESTING Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below